CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
ACQUISITION DE THÉRAPIE CITRATE ET DES PRODUITS HÉMOFILTRATION | Government contract · CanPursue
Contracts
terminated

ACQUISITION DE THÉRAPIE CITRATE ET DES PRODUITS HÉMOFILTRATION

Institut de Cardiologie de Montréal.VANTIVE ULC24-25-09-087
Watch
Total contract value
$1.4M
Original award value
$1.5M
Start
Sep 17, 2024
End
Jul 31, 2026

Timeline

Official
  • AwardedSep 17, 2024. Original award value: $1.5M
  • Observed expiryJul 31, 2026
Contract number
24-25-09-087
Awarded
Sep 17, 2024
Instrument
—
Status
terminated
Amendments
0 amendments
Source
SEAO
20017370
Related procurement
View full record